Patents by Inventor Matthew Crouthamel

Matthew Crouthamel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20250120995
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: December 20, 2024
    Publication date: April 17, 2025
    Inventors: Heng SONG, Kefeng SUN, Matthew CROUTHAMEL, Grace CHEN, Andy Z. X. ZHU, Ingrid Nicolle MICHON, Howard James BURT, Zoe Elizabeth BARTER, Sibylle NEUHOFF
  • Use of maribavir in treatment regimens
    Patent number: 12213989
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Grant
    Filed: April 25, 2024
    Date of Patent: February 4, 2025
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Heng Song, Kefeng Sun, Matthew Crouthamel, Grace Chen, Andy Z. X. Zhu, Ingrid Nicolle Michon, Howard James Burt, Zoe Elizabeth Barter, Sibylle Neuhoff
  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20240285663
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: April 25, 2024
    Publication date: August 29, 2024
    Inventors: Heng SONG, Kefeng SUN, Matthew CROUTHAMEL, Grace CHEN, Andy Z. X. ZHU, Ingrid Nicolle MICHON, Howard James BURT, Zoe Elizabeth BARTER, Sibylle NEUHOFF
  • USE OF MARIBAVIR IN TREATMENT REGIMENS
    Publication number: 20240156849
    Abstract: Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 16, 2024
    Applicants: Takeda Pharmaceuticals U.S.A., Inc, Certara USA, Inc.
    Inventors: Heng Song, Kefeng Sun, Matthew Crouthamel, Grace Chen, Andy Z.X. Zhu, Ingrid Nicolle Michon, Howard James Burt, Zoe Elizabeth Barter, Sibylle Neuhoff